Further studies in a large population of patients with COVID-19 would be needed to elucidate if TGM3 could be related to the ability of SARS-CoV-2 to infect epithelial airway cells and act as a biomarker for pulmonary damage associated with COVID-19. The gene discussed is TGM3; the disease is COVID-19.